Cart
sales@molnova.com
hCAII-IN-9
hCAII-IN-9
Catalog No. M36504
hCAII-IN-9 is a potent carbonic anhydrase inhibitor with IC50 values of 1.18 μM for hCA II, 0.17 μM for hCA IX, and 2.99 μM for hCA XII. It is not blood-brain barrier permeable.
| Size | Price / USD | Stock | Quantity |
| 2MG | 103 | Get Quote |
|
| 5MG | 141 | Get Quote |
|
| 10MG | 204 | Get Quote |
|
| 25MG | 334 | Get Quote |
|
| 50MG | 507 | Get Quote |
|
| 100MG | 714 | Get Quote |
|
| 500MG | 1467 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamehCAII-IN-9
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Hussain Z, et al. Synthesis and Evaluation of Amide and Thiourea Derivatives as Carbonic Anhydrase (CA) Inhibitors. ACS Omega. 2022 Dec 6;7(50):47251-47264. ?
molnova catalog
related products
-
Brinzolamide
Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor.
-
Hydrochlorothiazide
Hydrochlorothiazide is a first line diuretic compound of the thiazide class.
-
hCAI/II-IN-6
hCAI/II-IN-6 is a selective and orally active inhibitor of human carbonic anhydrase (CA). hCAI/II-IN-6 inhibited hCA I, hCA II, hCA VII, and hCA XII with Ki values of 220, 4.9, 6.5, and ＞50,000 nM.
